Search results
Author(s):
Alexander G Truesdell
,
Matheen A Khuddus
,
Sara C Martinez
,
et al
Added:
3 years ago
“When you fail to prepare, you’re preparing to fail.”
– Coach John Wooden
Ongoing technological and procedural innovations increasingly permit the safe and effective performance of ever more high-risk and complex percutaneous coronary interventions (PCI) in the modern cardiac catheterization laboratory. Anatomic characteristics of higher risk include unprotected distal left main stenosis,…
View more
Author(s):
Christopher P Cannon
Added:
6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Randomized Placebo-Controlled Trial of Anacetrapib in 30,449 Patients with Atherosclerotic Vascular Disease (REVEAL).
Filmed by Radcliffe Cardiology on-site at ESC 2017.
View more
Author(s):
Marianne Brodmann
Added:
4 years ago
Prof Marianne Brodmann (Medical University of Graz, AT) discusses safety of pacilitaxel coated balloons.
Filmed on site by Radcliffe Cardiology.
Questions:
1.There have been safety concerns with paclitaxel DCB's. What is your take on this? (00:09)
2.Are you still implanting drug coated balloons? (02:16)
View more
Author(s):
Colin Berry
Added:
6 years ago
In this video, Dr Colin Berry describesthe DEFINE-FLAIR study in his own words.
View more
Author(s):
Deepak L Bhatt
Added:
5 years ago
Deepak Bhatt discusses the ODYSSEY Outcomes trial - alirocumab in patients after acute coronary syndrome.
Filmed by Radcliffe Cardiology on-site at the American College of Cardiology congress 2018 in Orlando, USA
View more
Author(s):
Myung Ho Jeong
,
Bill D Gogas
Added:
2 years ago
In this first episode of Leading Cath & Translational Labs, Prof Myung Ho Jeong, Director of Korea, Cardiovascular Stent Research Institute and Cardiovascular Convergence Research Center, Korea introduces the work of the Kye Hun Kim’s Lab located at Chonnam National University Hospital, Gwangju.
View more
Author(s):
Bill D Gogas
,
Duk-Woo Park
Added:
2 years ago
In this video, USC Editor-in Chief Dr Bill Gogas discusses the upcoming 2021 Complex PCI event with Dr Duk-Woo Park (Asan Medical Center, Seoul, KR). Dr Park provides an overview of what we can expect to see at Complex PCI this year.
View more
Author(s):
Scott Solomon
Added:
1 year ago
In this short interview, Dr Scott Solomon (Brigham And Women's Hospital & Harvard Medical School, Boston, MA, US) discusses the design and baseline of the DELIVER trial.
This trial was designed to evaluate the effects of the dapagliflozin on cardiovascular death, heart failure (HF) hospitalization, or urgent HF visits in patients with HF with mildly reduced and preserved left ventricular ejection…
View more
Author(s):
Yasmin S Hamirani
,
Hussain Isma’eel
,
Irfan Zeb
,
et al
Added:
3 years ago
The prevalence of heart failure and the resultant mortality has continued to rise despite increased understanding of the pathogenesis and improvement in management strategies.1 Left ventricular (LV) dysfunction is the final stage of most primary cardiovascular diseases, and greater severity is directly correlated with worse prognosis. The principal manifestation of heart failure progression is a…
View more
Author(s):
James C Blankenship
,
Tanawan Riangwiwat
,
Bill D Gogas
Added:
3 years ago
In this practice-focused presentation, Dr Tanawan Riangwiwat (Geisinger Medical Center, Danville, PA, US) talks about radial access, sheath selection and discusses vascular access complications of transradial access for cardiac catheterization that invasive cardiologist and cardiac catheterization team members should be aware of.
After the presentation, Dr Riangwiwat is joined by Dr James C…
View more